Adoptive immunotherapy with ex vivo generated cytotoxic T lymphocytes (CTLs) is applied for the treatment of leukemia relapses or viral infections after allogeneic stem cell transplantation. A common problem of adoptive immunotherapy strategies is the ex vivo expansion of the generated T cells to sufficient numbers. CTLs can be efficiently expanded by ectopic expression of the human telomerase gene (hTert). However, hTert transduction may also increase the chance for malignant transformation. Therefore, we explored the feasibility of suicide gene control of ex vivo generated CTLs expanded through the ectopic expression of hTert. To this end, we compared the efficacy of the new Escherichia coli-nitroreductase (E. coli-Ntr) suicide gene with the well-known herpes simplex virus-thymidine kinase (HSV-Tk). Introduction of hTert provided the transduced CTLs with a distinct growth advantage over the nontransduced CTLs. The hTert-E. coli-Ntr double-transduced CTLs retained their antigenspecific functions. Treatment of hTert-E. coli-Ntr doubletransduced CTLs with metronidazole significantly inhibited the proliferation to a similar extent to the treatment of hTert-HSV-Tk double-transduced CTLs with ganciclovir. This is the first application of the E. colinitroreductase gene for the elimination of human T cells with metronidazole.
graft-versus-leukemia (GvL) effect of allo-SCT is mainly mediated by donor-derived alloreactive cytotoxic T lymphocytes (CTLs). 1, 2 These findings led to the successful introduction of donor lymphocyte infusions (DLIs) as treatment of recurrent CML after allo-SCT. 3, 4 The GvL effects of allo-SCT and DLI are, however, frequently associated with graft-versus-host disease (GvHD), because the donor T cells are not selected for tissue or cell specificity. Effective separation of the beneficial GvL or graft-versus-infection effects from GvHD may be possible by the adoptive immunotherapy of patients with ex vivo generated tumor or virus-specific CTLs. For instance, ex vivo generated CTLs specific for the minor histocompatibility antigens (mHags) HA-1 and HA-2 can be used for adoptive immunotherapy of relapsed leukemia with a low risk of GvHD. 5, 6 Ex vivo generated CMV-specific CTL has been applied to the treatment of CMV viral infections. 7 Ex vivo generation of virus or tumor antigen-specific CTLs for adoptive immunotherapy appears feasible. However, in general, ex vivo generated T cells show a limited replicative potential, [6] [7] [8] [9] which is a major problem of adoptive immunotherapy approaches.
A critical factor determining the life span of T lymphocytes is telomere length. 10 The telomerase enzyme (hTert) can preserve and extend the telomeres of actively dividing cells. 11 Constitutive telomerase expression in nonmalignant cells is limited to stem cells 12 and telomerase is only transiently expressed in activated T cells. 13 Ectopic expression of hTert in CTLs leads to vigorous expansion of human CTLs.
14,15 hTert-transduced CTLs proliferate in an antigen-dependent manner and retain all antigen-specific functions.
14 Nonetheless, uncontrolled growth in vivo or malignant transformation of hTert-transduced CTLs are major risks that preclude the use of hTert-transduced CTLs for clinical applications. In addition, ectopic hTert expression in CTLs may intensify the adverse effects mediated by adoptively transferred T cells, such as GvHD or autoimmune-like syndromes. We therefore examined the possibility of controlling CTLs expanded through the ectopic expression of hTert. To this end, we compared the efficacy of the new E. coli-nitroreductase (E. coli-Ntr) gene to that of the herpes simplex virus-thymidine kinase (HSV-Tk) gene, which has been applied successfully in different clinical settings. [16] [17] [18] [19] The suicide gene E. coli-Ntr converts the anti-protozoan drug metronidazole (MTZ) into a metabolite toxic for mammalian cells. 20, 21 The E. coli-Ntr suicide gene is effective on both proliferating and nonproliferating cells in contrast to the HSV-Tk suicide gene that only acts on actively dividing cells. Thus far, the E. coli-Ntr gene has been used mainly in solid tumor models in combination with the experimental prodrug CB1954. [22] [23] [24] [25] [26] Although the effectivity of E. coli-Ntr in eliminating mouse T cells was described, 27 it has, to our knowledge, not yet been used in human T cells.
Materials and methods
mHag HA-2-specific CTL clone D1.9
The mHag HA-2-specific CTL clone D1.9 was generated in vitro from a healthy HLA-A*0201 þ HA-2 À donor using HA-2 peptide pulsed autologous dendritic cells as antigenpresenting cells, as described previously. 28 
Retroviral constructs and virus production
The bicistronic retroviral vector pLZRS-hTert-IRES-GFP was kindly provided by Dr H Spits (Netherlands Cancer Institute, Amsterdam, The Netherlands) and is described in detail elsewhere 14 ( Figure 1 ). Two bicistronic retroviral vectors coding for either the suicide genes HSV-Tk or E. coli-Ntr combined with an easily selectable marker gene, the intracytoplasmically truncated form of the human nerve growth factor receptor (NGF-R), were constructed (respectively, pLZRS-Tk-IRES-NGF-R and pLZRS-Ntr-IRES-NGF-R) (Figure 1 ). The suicide gene and NGF-R are expressed under the control of the Moloney murine leukemia virus long-terminal repeat (LTR) using an IRES motif for co-expression ( Figure 1 ). The pLZRS-Tk-IRES-NGF-R vector was constructed by cloning a 1.2-kb BglII fragment of the DMJSVTK retroviral vector (kindly provided by HE Heslop, St Jude Children's Research Hospital, Memphis, TN, USA) into the polylinker of the pLZRS-IRES-NGF-R retroviral vector (kindly provided by MHM Heemskerk, Department of Experimental Hematology, LUMC, Leiden, The Netherlands). The pLZRSNtr-IRES-NGF-R vector was constructed by cloning a 833 bp HindIII fragment of the pxLNC-Ntr retroviral vector 22 (kindly provided by P Searle, CRC Technologies, Birmingham, UK) into the polylinker of the pBluescript II SK expression vector (Stratagene, La Jolla, CA, USA). A correctly oriented 7850 bp XhoI/EcoRI fragment of the thus obtained plasmid was cloned into the polylinker of the pLZRS-IRES-NGF-R retroviral vector. Virus supernatants from all vectors were produced using the Phoenix amphotrophic packaging cell line (kindly provided by G Nolan, Stanford University, Stanford, CA, USA), as previously described.
14,29
Retroviral transduction of the HA-2-specific CTL clone D1.9
The recombinant human fibronectin fragments (Retronectin, Takara, Otsu, Japan) transduction procedure was based on a method originally developed by Hanenberg et al, 30 with the modifications described by Hooijberg et al.
14 Briefly, the HA-2-specific CTL clone D1.9 was stimulated with a feeder cell mixture containing 1 Â 10 6 /ml irradiated (8000 Gy) PBMC from five donors, 1 mg/ml leukoagglutinin (Pharmacia, Uppsala, Sweden) and 20 U/ ml IL-2 (Cetus, Emeryville, CA, USA) in IMDM for 48 h. Subsequently, the CTLs were plated on retronectin-coated 24-well plates (1À2 Â 10 5 CTL/wel) in 0.2 ml of complete medium mixed with 1 ml of thawed retroviral supernatant. Cells were cultured at 371C overnight, washed and transferred to 24-well culture plates (Costar, Corning, NY, USA). Transduction efficiency was determined by FACS staining for green fluorescent protein (GFP) or NGF-R expression. For double transduction, the procedure described above was repeated using 495% singletransduced CTL.
Cytotoxicity assay

Standard, 4-h 51
Cr release assays using EBV-transformed B-cell lines (EBV-LCL) as target cells were performed as described previously. 31 The percent-specific lysis was calculated using the following formula: 100 Â (cpm experimental releaseÀcpm spontaneous release)/(cpm maximal releaseÀ cpm spontaneous release).
Interferon gamma (IFN-g) production
The double-transduced HA-2-specific CTL clone D1.9 (1 Â 10 4 cells/well) was stimulated in duplicate 96-well flatbottom microtiter plates for 48 h in IMDM supplemented with 10% HS, and 20 U/ml IL-2. Supernatants were harvested and tested for IFN-g production using IFN-gspecific ELISA (Pelikine, CLB, Amsterdam, The Netherlands).
T cell proliferation-inhibition assay
The double-transduced HA-2-specific CTL clone D1.9 (1 Â 10 4 cells/well) was stimulated with CD3/CD28-coated beads or PMA/ionomycin in triplicate 96-well roundbottom microtiter plates for 5 days in IMDM supplemented with 10% HS and 20 U/ml IL-2. The prodrugs were added to the cell cultures at different concentrations 
Results
Transduction of suicide genes into hTert transduced HA-2-specific CTLs
We introduced the hTert cDNA into the HA-2-specific CTL clone D1.9 by retroviral transduction. After 2 weeks of antigen-specific stimulation, hTert þ CTLs were purified by FACS sorting of GFP þ cells. Highly purified hTert þ / GFP þ cells were expanded in continuous culture for a period of over 3 months in the presence of IL-2. In agreement with earlier reports, 14 hTert transduced CTLs expanded vigorously, but remained entirely dependent on antigen exposure.
Selected, hTert þ HA-2-specific CTLs were subsequently transduced with either the E. coli-Ntr-cDNA or with the HSV-Tk-cDNA by retroviral transduction. Double-transduced CTLs were purified up to 95% by FACS sorting for GFP þ and NGF-R þ cells. The introduction of the suicide genes did not affect the growth rate of the hTert-transduced CTLs over a period of months (data not shown). To determine whether retroviral gene transduction affects the effector functions of HA-2-specific CTLs, we tested hTert/ suicide gene double-transduced HA-2-specific CTLs for antigen-specific cytotoxic activity and IFN-g production. Double transduction of the HA-2-specific CTLs with hTert and the suicide genes E. coli-Ntr or HSV-Tk did not affect the cytotoxic activity. The nontransduced CTLs, mocktransduced CTLs, as well as hTert/suicide gene doubletransduced CTLs, effectively lysed HA-2 peptide pulsed and HA-2-positive target cells at low E : T ratios (Figure 2a , c, e, respectively). HA-2-negative targets and K562 cells were not recognized, illustrating the antigen specificity of the lytic activity. Similarly, hTert/suicide gene doubletransduced CTLs produced high levels of IFN-g upon HA-2-specific stimulation (Figure 2b, d, f) , but not on nonspecific stimulation.
Suicide gene control of hTert-transduced HA-2-specific CTLs
To compare the efficacy of the E. coli-Ntr and HSV-Tk suicide gene/prodrug systems, we tested the proliferation of hTert/suicide gene double-transduced CTLs in the presence of prodrugs MTZ and GCV, respectively. The hTert/ suicide gene-transfected CTLs showed significant proliferation against OKT3/CD28-coated beads in the absence of prodrugs. MTZ inhibited the proliferation of the hTert/ Ntr-transduced CTLs for 77% at 1 mM, which was comparable to the proliferation inhibition induced by the prodrug CB 1954 (data not shown). At this concentration, hTtert/mock-or hTert/HSV-Tk-transduced CTLs were not inhibited significantly (Figure 3, closed bars) . MTZ was toxic for all cells at higher concentrations (data not shown). The concentration of 1 mM of GCV inhibited the proliferation of hTert/HSV-Tk double-transduced CTLs by 79% (Figure 3, open bars) ; this is comparable to that described in the literature. 32 This inhibition was also suicide genespecific, since GCV did not significantly inhibit the proliferation of hTert/mock-or hTert/Ntr double-transduced CTLs (Figure 3 ). Like MTZ, GCV was toxic at higher concentrations and inhibited the proliferation of all cells (data not shown). In separate assays, similar optimal working concentrations of the prodrugs GCV and MTZ were found for CTLs that were transduced only with E. coli-Ntr or HSV-Tk, but not with hTert (data not shown).
Discussion
Here, we studied the in vitro control by the suicide genes E. coli-Ntr and HSV-Tk of mHag HA-2-specific CTLs expanded through ectopic expression of hTert. Retroviral double transduction of suicide genes and hTert into HA-2-specific CTLs is straightforward and does not affect antigen-specific functions. Both suicide gene/prodrug systems significantly inhibited the proliferation of hTerttransduced CTLs at prodrug concentrations that have been shown to be effective for non-hTert-transduced CTLs. 32 The efficacy of the new E. coli-Ntr suicide gene system is also comparable to another newly described suicide gene system, using a chimeric human NGF-R/Fas molecule. 33 The transduced cells can be purified up to 95% by FACS sorting for GFP þ and NGF-R þ cells. Thus, a low percentage of CTL will remain that is not sensitive to the prodrugs MTZ or ganciclovir. Allthough clinical application of these highly purified E. coli-Ntr or HSV-Tktransduced cells will significantly reduce the risk of GvHD, there remains a residual nontransduced CTL population that can still cause a clinical problem. The suicide gene approach may represent a strategy to control ex vivo expanded CTLs by hTert transduction. It may be used to prevent severe undesired effects such as malignant transformation. As yet, it is unclear whether hTert-transduced CTLs will undergo malignant transformation. In two previous reports, ectopic hTert expression in human somatic cells did not to lead to changes associated with a transformed phenotype. 15, 34 In our assays, the hTerttransduced HA-2-specific CTLs showed significant growth advantage in comparison to mock-transduced CTLs, but were still dependent on antigen-specific restimulations and IL-2 for in vitro expansion. Furthermore, the hTert/ HSV-Tk double-transduced CTLs were susceptible to GCV which kills the cells by the induction of apoptosis, 35, 36 indicating that the hTert transduction does not affect the sensitivity to apoptosis, as suggested by others. 37 Telomerase is a proto-oncogene that increases the susceptibility for malignant transformation. Virtually all malignant tumors show high telomerase expression, 12, 38 which justifies reservations against the use of ex vivo generated CTLs, expanded through hTert as immunotherapeutic tools. 14 The suicide gene approach may overcome the reluctance to use of hTert-transduced cells for immunotherapy.
Our study indicates that control of hTert-transduced CTLs by the suicide gene HSV-Tk is comparable to control by the new suicide gene E. coli-Ntr. The HSV-Tk/GCV system is a well-known suicide gene system and worked in our in vitro assays with an efficacy comparable to that described in literature. 32 However, there are several known drawbacks of HSV-Tk. For instance, HSV-Tk is immunogenic. HSV-Tk-transduced cells can be eliminated by an allo-immune response of the recipient directed against multiple epitopes of the HSV-Tk gene. 33 The prodrug GCV is routinely used to treat CMV infections that frequently occur after allo-SCT. The inadvertent elimination of HSVTk-transduced DLI due to ganciclovir treatment of CMVinfected SCT patients has been documented. 17 Therefore, we assayed the feasibility of an alternative suicide gene/ prodrug system: E. coli-Ntr in combination with MTZ. At attainable plasma concentrations of MTZ, proliferation of E. coli-Ntr-transduced CTLs is inhibited. The main advantage of this system is that MTZ is not used routinely for the treatment of infection post SCT. Another advantage of the E. coli-Ntr/MTZ system is that also nondividing E. coli-Ntr-transduced cells are affected, 25, 39 whereas HSVTk only acts on actively dividing cells. The technique of cotransfection of E. coli-Ntr in all hTert-transduced CTLs may be simplified by the construction of a tricistronic vector containing the selection gene NGF-R, the hTert gene and E. coli-Ntr gene linked by two IRES sequences. Such a vector will also enable easy purification of transduced CTL using magnetic beads coated with anti-NGF-R antibodies to be used for clinical application.
In conclusion, we demonstrate that hTert-transduced CTLs can be effectively controlled by suicide genes. Moreover, we show for the first time that the proliferation of E. coli-Ntr suicide genetransduced human mHag specific T cells is significantly inhibited upon treatment with MTZ.
